Conduit Net Income Per Share from 2010 to 2024

CDT Stock   0.09  0.01  7.61%   
Conduit Pharmaceuticals Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss will likely drop to -0.0084 in 2024. From the period from 2010 to 2024, Conduit Pharmaceuticals Net Loss quarterly data regression had mean square error of  0 and mean deviation of  0.05. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
(0.01)
Current Value
(0.01)
Quarterly Volatility
0.07572586
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Conduit Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Conduit Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 159.5 K, Selling General Administrative of 4.1 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Conduit financial statements analysis is a perfect complement when working with Conduit Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Conduit Pharmaceuticals Correlation against competitors.
For more information on how to buy Conduit Stock please use our How to Invest in Conduit Pharmaceuticals guide.

Latest Conduit Pharmaceuticals' Net Income Per Share Growth Pattern

Below is the plot of the Net Income Per Share of Conduit Pharmaceuticals over the last few years. It is Conduit Pharmaceuticals' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Conduit Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Net Income Per Share10 Years Trend
Slightly volatile
   Net Income Per Share   
       Timeline  

Conduit Net Income Per Share Regression Statistics

Arithmetic Mean(0.19)
Coefficient Of Variation(40.03)
Mean Deviation0.05
Median(0.21)
Standard Deviation0.08
Sample Variance0.01
Range0.2747
R-Value0.48
Mean Square Error0
R-Squared0.23
Significance0.07
Slope0.01
Total Sum of Squares0.08

Conduit Net Income Per Share History

2024 -0.008388
2023 -0.007988
2022 -0.28

About Conduit Pharmaceuticals Financial Statements

Conduit Pharmaceuticals shareholders use historical fundamental indicators, such as Net Income Per Share, to determine how well the company is positioned to perform in the future. Although Conduit Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Conduit Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Conduit Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss(0.01)(0.01)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Conduit Stock Analysis

When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.